RATIONALE: Several family-based studies have identified genetic linkage for lung function and airflow obstruction to chromosome 2q. OBJECTIVES: We hypothesized that merging results of high-resolution single nucleotide polymorphism (SNP) mapping in four separate populations would lead to the identification of chronic obstructive pulmonary disease (COPD) susceptibility genes on chromosome 2q. METHODS: Within the chromosome 2q linkage region, 2,843 SNPs were genotyped in 806 COPD cases and 779 control subjects from Norway, and 2,484 SNPs were genotyped in 309 patients with severe COPD from the National Emphysema Treatment Trial and 330 community control subjects. Significant associations from the combined results across the two case-control studies were followed up in 1,839 individuals from 603 families from the International COPD Genetics Network (ICGN) and in 949 individuals from 127 families in the Boston Early-Onset COPD Study. MEASUREMENTS AND MAIN RESULTS: Merging the results of the two case-control analyses, 14 of the 790 overlapping SNPs had a combined P < 0.01. Two of these 14 SNPs were consistently associated with COPD in the ICGN families. The association with one SNP, located in the gene XRCC5, was replicated in the Boston Early-Onset COPD Study, with a combined P = 2.51 x 10(-5) across the four studies, which remains significant when adjusted for multiple testing (P = 0.02). Genotype imputation confirmed the association with SNPs in XRCC5. CONCLUSIONS: By combining data from COPD genetic association studies conducted in four independent patient samples, we have identified XRCC5, an ATP-dependent DNA helicase, as a potential COPD susceptibility gene.
RATIONALE: Several family-based studies have identified genetic linkage for lung function and airflow obstruction to chromosome 2q. OBJECTIVES: We hypothesized that merging results of high-resolution single nucleotide polymorphism (SNP) mapping in four separate populations would lead to the identification of chronic obstructive pulmonary disease (COPD) susceptibility genes on chromosome 2q. METHODS: Within the chromosome 2q linkage region, 2,843 SNPs were genotyped in 806 COPD cases and 779 control subjects from Norway, and 2,484 SNPs were genotyped in 309 patients with severe COPD from the National Emphysema Treatment Trial and 330 community control subjects. Significant associations from the combined results across the two case-control studies were followed up in 1,839 individuals from 603 families from the International COPD Genetics Network (ICGN) and in 949 individuals from 127 families in the Boston Early-Onset COPD Study. MEASUREMENTS AND MAIN RESULTS: Merging the results of the two case-control analyses, 14 of the 790 overlapping SNPs had a combined P < 0.01. Two of these 14 SNPs were consistently associated with COPD in the ICGN families. The association with one SNP, located in the gene XRCC5, was replicated in the Boston Early-Onset COPD Study, with a combined P = 2.51 x 10(-5) across the four studies, which remains significant when adjusted for multiple testing (P = 0.02). Genotype imputation confirmed the association with SNPs in XRCC5. CONCLUSIONS: By combining data from COPD genetic association studies conducted in four independent patient samples, we have identified XRCC5, an ATP-dependent DNA helicase, as a potential COPD susceptibility gene.
Authors: Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson Journal: Am J Hum Genet Date: 2003-12-15 Impact factor: 11.025
Authors: Alka Malhotra; Andy P Peiffer; Darin T Ryujin; Tami Elsner; Richard E Kanner; Mark F Leppert; Sandra J Hasstedt Journal: Am J Respir Crit Care Med Date: 2003-06-05 Impact factor: 21.405
Authors: N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara Journal: JAMA Date: 1994-11-16 Impact factor: 56.272
Authors: Edwin K Silverman; Lyle J Palmer; Jonathan D Mosley; Matthew Barth; Jody M Senter; Alison Brown; Jeffrey M Drazen; David J Kwiatkowski; Harold A Chapman; Edward J Campbell; Michael A Province; D C Rao; John J Reilly; Leo C Ginns; Frank E Speizer; Scott T Weiss Journal: Am J Hum Genet Date: 2002-03-25 Impact factor: 11.025
Authors: Laila M Poisson; Benjamin A Rybicki; Steven W Coon; Jill S Barnholtz-Sloan; Gary A Chase Journal: BMC Genet Date: 2003-12-31 Impact factor: 2.797
Authors: Ying Shi; Jiaofei Cao; Jane Gao; Liang Zheng; Andrew Goodwin; Chang Hyoek An; Avignat Patel; Janet S Lee; Steven R Duncan; Naftali Kaminski; Kusum V Pandit; Ivan O Rosas; Augustine M K Choi; Danielle Morse Journal: Am J Respir Crit Care Med Date: 2012-06-28 Impact factor: 21.405
Authors: Mateusz Siedlinski; Dustin Tingley; Peter J Lipman; Michael H Cho; Augusto A Litonjua; David Sparrow; Per Bakke; Amund Gulsvik; David A Lomas; Wayne Anderson; Xiangyang Kong; Stephen I Rennard; Terri H Beaty; John E Hokanson; James D Crapo; Christoph Lange; Edwin K Silverman Journal: Hum Genet Date: 2013-01-09 Impact factor: 4.132
Authors: Craig P Hersh; Edwin K Silverman; Jody Gascon; Soumyaroop Bhattacharya; Barbara J Klanderman; Augusto A Litonjua; Véronique Lefebvre; David Sparrow; John J Reilly; Wayne H Anderson; David A Lomas; Thomas J Mariani Journal: Am J Respir Crit Care Med Date: 2011-02-17 Impact factor: 21.405
Authors: Anne H Agler; Ronald G Crystal; Jason G Mezey; Jennifer Fuller; Chuan Gao; Joyanna G Hansen; Patricia A Cassano Journal: COPD Date: 2013-08 Impact factor: 2.409
Authors: Deog Kyeom Kim; Michael H Cho; Craig P Hersh; David A Lomas; Bruce E Miller; Xiangyang Kong; Per Bakke; Amund Gulsvik; Alvar Agustí; Emiel Wouters; Bartolome Celli; Harvey Coxson; Jørgen Vestbo; William MacNee; Julie C Yates; Stephen Rennard; Augusto Litonjua; Weiliang Qiu; Terri H Beaty; James D Crapo; John H Riley; Ruth Tal-Singer; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2012-11-09 Impact factor: 21.405